Download PDF

Diabetologia

, Volume 27, Issue 5, pp 529–534 | Cite as

Impaired growth hormone response to human pancreatic growth hormone releasing factor [GRF (1–44)] in type 2 (non-insulin-dependent) diabetes

  • N. T. Richards
  • S. M. Wood
  • N. D. Christofides
  • S. C. Bhuttacharji
  • S. R. Bloom
Originals
Received:
Revised:

Summary

Human pancreatic growth hormone releasing factor [GRF(1–44)] is the largest molecule of several peptides recently isolated from pancreatic tumours associated with acromegaly. It has been shown to stimulate the release of growth hormone in normal subjects and provides a safe and reliable tool for examining growth hormone release. A study was conducted to examine the release of growth hormone in patients with Type 1 (insulin-dependent) and Type 2 (non-insulin-dependent) diabetes. GRF(1–44) stimulated the release of growth hormone in normal subjects and produced no side effects. A response of similar magnitude occurred in Type 1 diabetic patients despite their concomitant hyperglycaemia. In contrast, the response in Type 2 diabetes was significantly impaired compared with normal volunteers (p<0.05) and Type 1 diabetic patients (p<0.02). These findings may well indicate that there is a defect in central hormonal control in Type 2 diabetes.

Key words

Diabetes growth hormone releasing factor 
Download to read the full article text

References

  1. 1.
    Hansen AP (1973) Abnormal serum growth hormone response to exercise in maturity onset diabetes. Diabetes 22: 619–28Google Scholar
  2. 2.
    Hansen AP (1970) Abnormal serum growth hormone response to exercise in juvenile diabetics. J Clin Invest 49: 1467–1478Google Scholar
  3. 3.
    Burday SZ, Fine PH, Schalch DS (1968) Growth hormone secretion in response to arginine infusion in normal and diabetic subjects: Relationship to blood glucose levels. J Lab Clin Med 71: 897–911Google Scholar
  4. 4.
    Merimee TJ, Burgess JA, Rabinowitz D (1966) Arginine infusion in maturity onset diabetes mellitus. Lancet 1: 1300–1301Google Scholar
  5. 5.
    Lundbaek K, Christensen NJ, Jensen VA, Johansen K, Olsen TS, Hansen AP, Orskov H, Osterby R (1971) The pathogenesis of diabetic angiopathy and growth hormone. Dan Med Bull 18: 1–7Google Scholar
  6. 6.
    Lundbaek K, Margensen CE, Anderson MJE (1974) Increased kidney size and glomeralar filtration rate in untreated juvenile diabetes normalization by strict insulin treatment. Diabetologia 10: 378 (Abstract)Google Scholar
  7. 7.
    Frohman LA, Szabo M, Berelowitz M, Stachura ME (1980) Partial purification and characterisation of a peptide with growth hormone releasing activity from extrapituitary tumours in patients with acromegaly. J Clin Invest 65: 43–54Google Scholar
  8. 8.
    Rivier J, Spiess J, Thorner M, Vale W (1983) Characterisation of a growth hormone releasing factor from a human pancreatic tumour. Nature 300: 276–278Google Scholar
  9. 9.
    Thorner MO, Perryman RL, Cronin MJ, Rogol AD, Draznin M, Johnson A, Vale W, Horvath E, Kovacs K (1982) Somatotroph hyperplasia, successful treatment of acromegaly by removal of a pancreatic islet tumour secreting a growth hormone releasing factor. J Clin Invest 70: 965–977Google Scholar
  10. 10.
    Guilleman R, Brazeau P, Bohlen PE, Esch F, Ling N, Wehrenberg W (1982) Growth hormone releasing factor from a human pancreatic tumour that caused acromegaly. Science 218: 585–587Google Scholar
  11. 11.
    Wood SM, Ch'ng JLC, Adams EF, Webster JD, Joplin GF, Mashiter K, Bloom SR (1983) Abnormalities of growth hormone releasing factor GRF (1–44) in acromegaly and hypopituitarism. Br Med J 286: 1687–1691Google Scholar
  12. 12.
    Adams EF, Brajkovich IE, Mashiter K (1981) Growth hormone and prolactin secretion by dispersed cell cultures of human pituitary adenomas: long term effects of hydrocortisone, oestradiol, insulin, 3,5,3 tri-iodo thyronine and thyroxine. J Clin Endocrinol Metab 53: 381–386Google Scholar
  13. 13.
    O'Shaughnessy DJ (1982) Antibodies. In: Bloom SR, Long RG (eds) Radioimmunoassay of gut regulatory peptides. WB Saunders, London, pp 11–20Google Scholar
  14. 14.
    Hunter WM, Greenwood FC (1982) Preparation of iodine-131 labelled human growth hormone of high specific activity. Nature 194: 495–496Google Scholar
  15. 15.
    Tchobroutsky G, Rosselin G, Assan R, Derot M (1968) Arginine infusion in diabetes mellitus. Lancet 2: 498–499Google Scholar
  16. 16.
    Tchobroutsky G, Assan R, Rosselin G, Derot M (1967) Taux plasmatiques de l'hormone somatrope chez de diabðiques premiers résultats de déterminations a jeun, au repos et après administration d'arginine où d'insuline. Ann Endocrinol Paris 28: 766–775Google Scholar
  17. 17.
    Fatourechi V, Molnar GD, Service FJ, Ackerman E, Rosevear JW, Moxness KE, Taylor WF (1969) Growth hormone and glucose interrelationships in diabetes: studies with insulin infusion during continuous blood glucose analysis. J Clin Endocrinol 29: 319–327Google Scholar
  18. 18.
    Mims RB, Scott CL, Modebe OM, Bethune JE (1973) Prevention of L-dopa induced growth hormone stimulation by hyperglycaemia. J Clin Endocrinol Metab 37: 660–663Google Scholar
  19. 19.
    Shibasaki T, Shizume K, Nakahara M, Masuda A, Jibiki K, Demura H, Wakabayashi I, Ling N (1984) Age related changes in plasma growth hormone response to growth hormone releasing factor in man. J Clin Endocrinol Metab 58: 212–214Google Scholar
  20. 20.
    Wehrenberg WB, Ling N, Bohlen P, Esch F, Brazeau P, Guilleman R (1982) Physiological roles of somatocrinin and somatostatin in the regulation of growth hormone secretion. Biochem Biophys Res Commun 109: 562–567Google Scholar
  21. 21.
    Kadowaki S, Iaminato T, Chiba I, Goto Y, Nozawa M, Seino Y, Matsukura S, Fujita T (1980) Somatostatin release from the isolated perfused diabetic rat pancreas. Diabetes 29: 960–963Google Scholar
  22. 22.
    Weir GC, Clore ET, Zmachinski CJ, Bonner Weir S (1981) Islet cell secretion in a new experimental model for non-insulin dependent diabetes. Diabetes 30: 590–595Google Scholar
  23. 23.
    Wood SM, Webster J, Bloom SR (1982) Regulatory peptides in Type 2 (non-insulin-dependent) diabetes. Diabetologia 22: 18 (Abstract)Google Scholar

Copyright information

© Springer-Verlag 1984

Authors and Affiliations

  • N. T. Richards
    • 1
  • S. M. Wood
    • 1
  • N. D. Christofides
    • 1
  • S. C. Bhuttacharji
    • 1
  • S. R. Bloom
    • 1
  1. 1.Department of Medicine, Royal Postgraduate Medical SchoolHammersmith HospitalLondonUK

Personalised recommendations